NeoGenomics, Inc. - ROE
NEO
Price:
$11.13
Market Cap:
$289.85M
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers. NeoGenomics' advanced testing capabilities encompass cytogenetics, which examines normal and abnormal chromosomes in relation to disease; fluorescence in-situ hybridization (FISH) for detecting and pinpointing specific DNA sequences and...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2004-03-16
Stock Exchange
NASDAQ
Ticker
NEO
PE Ratio
[-14.45]
ROE
[-11.82%]
Current Ratio
[4.42]
Dividend Yield
[0%]
Enterprise Value
[552.24M]
Dividend History
The ROE as of June 2026 (TTM) for NeoGenomics, Inc. (NEO) is -11.82%
According to NeoGenomics, Inc.’s latest financial reports and current stock price. The company's current ROE is -11.82%. This represents a change of 301.95% compared to the average of -2.94% of the last 4 quarters.
NeoGenomics, Inc. (NEO) Historical ROE (quarterly & annually)
How has NEO ROE performed in the past?
The mean historical ROE of NeoGenomics, Inc. over the last ten years is -4.67%. The current -11.82% ROE has changed 153.25% with respect to the historical average. Over the past ten years (40 quarters), NEO's ROE was at its highest in in the June 2021 quarter at 6.61%. The ROE was at its lowest in in the June 2025 quarter at -5.28%.
Average
-4.67%
Median
-2.02%
Minimum
-14.45%
Maximum
1.58%
NeoGenomics, Inc. (NEO) ROE by Quarter and Year
Discovering the peaks and valleys of NeoGenomics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.82%
Maximum Annual ROE = 1.58%
Minimum Annual Increase = -527.60%
Minimum Annual ROE = -14.45%
| Year | ROE | Change |
|---|---|---|
| 2025 | -12.91% | 48.01% |
| 2024 | -8.72% | -6.62% |
| 2023 | -9.34% | -35.36% |
| 2022 | -14.45% | 1.82% |
| 2021 | -0.75% | -225.34% |
| 2020 | 0.60% | -61.92% |
| 2019 | 1.58% | 91.52% |
| 2018 | 0.82% | -527.60% |
| 2017 | -0.19% | -94.15% |
| 2016 | -3.29% | 209.18% |
NeoGenomics, Inc. (NEO) Average ROE
How has NEO ROE performed in the past?
The current ROE of NeoGenomics, Inc. (NEO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.33%
5-year avg
-9.24%
10-year avg
-4.67%
NeoGenomics, Inc. (NEO) ROE vs. Peers
How is NEO’s ROE compared to its peers?
NeoGenomics, Inc.’s ROE is greater than Exagen Inc. (-113.53%), less than MDxHealth S.A. (402.97%), greater than Stereotaxis, Inc. (-153.21%), greater than Aclaris Therapeutics, Inc. (-55.89%), greater than Quanterix Corporation (-35.17%), greater than Sagimet Biosciences Inc. (-37.57%), greater than Sanara MedTech Inc. (-246.44%), greater than Arcturus Therapeutics Holdings Inc. (-36.55%), greater than Humacyte, Inc. (-2781.56%), greater than Alpha Teknova, Inc. (-24.32%),
| Company | ROE | Market cap |
|---|---|---|
| -113.53% | $109.69M | |
| 402.97% | $27.89M | |
| -153.21% | $183.74M | |
| -55.89% | $542.68M | |
| -35.17% | $159.69M | |
| -37.57% | $217.65M | |
| -246.44% | $201.79M | |
| -36.55% | $214.03M | |
| -2781.56% | $155.30M | |
| -24.32% | $280.94M |
Build a custom stock screener for NeoGenomics, Inc. (NEO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoGenomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
NeoGenomics, Inc. (NEO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like NeoGenomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is NeoGenomics, Inc.'s ROE?
How is the ROE calculated for NeoGenomics, Inc. (NEO)?
What is the highest ROE for NeoGenomics, Inc. (NEO)?
What is the 3-year average ROE for NeoGenomics, Inc. (NEO)?
What is the 5-year average ROE for NeoGenomics, Inc. (NEO)?
How does the current ROE for NeoGenomics, Inc. (NEO) compare to its historical average?